Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical Journal of the American Society of Nephrology : CJASN|October 31, 2024
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating ProteinsHiroki Kobayashi, Helen C Looker, Katsuhito Ihara, et al.
JCI Insight|June 24, 2024
Preanalytical considerations in quantifying circulating miRNAs that predict end-stage kidney disease in diabetesEiichiro Satake, Bozena Krolewski, Hiroki Kobayashi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2026
Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysisJonathan M Wilson, Jeffrey L Dage, Hui-Rong Qian, et al.
Kidney International|February 6, 2018
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests developmentNatalia Nowak, Jan Skupien, Adam M Smiles, et al.
Plos One|May 30, 2013
An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive functionKim Henriksen, Yaguo Wang, Mette G Sørensen, et al.
Diabetes Care|June 2, 2023
Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc AnalysisHiddo J L Heerspink, Naveed Sattar, Imre Pavo, et al.
Diabetes Care|September 5, 2020
Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without AlbuminuriaKatsuhito Ihara, Jan Skupien, Hiroki Kobayashi, et al.
Kidney International|April 12, 2017
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal diseaseMasayuki Yamanouchi, Jan Skupien, Monika A Niewczas, et al.
Diabetes Care|March 10, 2023
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc AnalysisHertzel C Gerstein, Shun-Fu Lee, Guillaume Paré, et al.
Science Translational Medicine|July 1, 2021
Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetesZaipul I Md Dom, Eiichiro Satake, Jan Skupien, et al.
Pageof 5